ClinicalTrials.Veeva

Menu

Naltrexone and Memantine Effects on Alcohol Drinking Behaviors

Yale University logo

Yale University

Status and phase

Completed
Phase 2

Conditions

Alcohol Drinking

Treatments

Drug: Naltrexone and Placebo first
Drug: Naltrexone and memantine first

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT01519063
P50AA012870 (U.S. NIH Grant/Contract)
1005006779

Details and patient eligibility

About

The purpose of this study is to evaluate the combined effects of the study medications naltrexone and memantine on alcohol drinking behaviors.

Full description

Participants will be randomized to receive a combination of naltrexone/memantine over a one week period and then participate in a laboratory session. During this session, participants are given an initial drink of alcohol followed by the choice to drink up to 12 more drinks over a three-hour period. These medications are hypothesized to reduce craving and number of drinks consumed prior to and after exposure to the initial drink of alcohol and during the three hour drinking period.

Enrollment

75 patients

Sex

All

Ages

21 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Ages 21-55
  • Able to read English at 6th grade level or higher and to complete study evaluations
  • Regular alcohol drinker

Exclusion criteria

  • Individuals who are seeking alcohol treatment
  • Medical conditions that would contraindicate the use of study medication
  • Regular use of other substances

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

75 participants in 2 patient groups, including a placebo group

Naltrexone and memantine
Experimental group
Description:
Treatment with Naltrexone and memantine first
Treatment:
Drug: Naltrexone and memantine first
Drug: Naltrexone and Placebo first
Naltrexone and Placebo
Placebo Comparator group
Description:
Treatment with naltrexone and placebo first
Treatment:
Drug: Naltrexone and memantine first
Drug: Naltrexone and Placebo first

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems